229 related articles for article (PubMed ID: 32030886)
1. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.
Yang Y; Song S; Meng Q; Wang L; Li X; Xie S; Chen Y; Jiang X; Wang C; Lu Y; Xin X; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
J Cell Mol Med; 2020 Mar; 24(5):2772-2790. PubMed ID: 32030886
[TBL] [Abstract][Full Text] [Related]
2. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
[TBL] [Abstract][Full Text] [Related]
3. miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
[TBL] [Abstract][Full Text] [Related]
4. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
[TBL] [Abstract][Full Text] [Related]
5. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.
Cai M; Chen Q; Shen J; Lv C; Cai L
J Cell Mol Med; 2018 Oct; 22(10):4721-4731. PubMed ID: 30117667
[TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
9. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
10. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.
Cloos PA; Christensen J; Agger K; Maiolica A; Rappsilber J; Antal T; Hansen KH; Helin K
Nature; 2006 Jul; 442(7100):307-11. PubMed ID: 16732293
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
[TBL] [Abstract][Full Text] [Related]
13. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
15. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
[TBL] [Abstract][Full Text] [Related]
16. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis.
Wang DY; Zou LP; Liu XJ; Zhu HG; Zhu R
Exp Mol Pathol; 2015 Dec; 99(3):399-408. PubMed ID: 26341139
[TBL] [Abstract][Full Text] [Related]
19. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract][Full Text] [Related]
20. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]